Viatris Innovation Gmbh

This study tested an experimental drug called cenerimod in 105 adults with active lupus. The goal was to see if it could safely reduce certain immune cells that cause inflammation. Participants took the drug or a placebo for up to 12 weeks while continuing their usual lupus medic…

This study tested a new drug, cenerimod, in 427 adults with moderate to severe systemic lupus erythematosus (SLE). The goal was to see if it could safely reduce lupus disease activity compared to a placebo over six months. Participants took one of four doses of cenerimod or a pla…

This study looked at how the drug cenerimod affects heart electrical activity (QT interval), how it interacts with birth control pills, and how charcoal changes its absorption. 97 healthy adults took part. The goal was to gather safety and drug interaction information, not to tre…

This study looked at how mild and moderate liver problems affect the way the body handles a single dose of the drug cenerimod. Researchers compared 24 adults—some with liver impairment and some healthy—to measure drug levels and safety. The goal was to gather information, not to …

This study is for research only and does not treat any disease. It looks at how safe a single dose of the drug cenerimod is and how the body absorbs and breaks it down. Twenty healthy volunteers (10 Japanese and 10 Caucasian) take part. The goal is to see if the drug acts differe…

This study looked at how a drug called cenerimod leaves the body. Six healthy men aged 45 to 65 took a single dose with a radioactive tag. Researchers measured the drug's breakdown and removal in urine, feces, and breath to understand its metabolism.

This study looked at how a single 16 mg dose of selatogrel is absorbed, broken down, and tolerated in 32 healthy adults (16 Japanese, 16 Caucasian). It was not meant to treat any disease. Participants stayed in a clinic for 3-4 days and had follow-up checks. The goal was to gathe…

This completed Phase 1 trial enrolled 6 healthy men to find out how much of the drug cenerimod enters the bloodstream after taking a pill. Participants took one tablet, then received a tiny radioactive version of the drug through an IV to track it. The study lasted about 3 months…

This study tested how the drug cenerimod is processed by the body in people with severe kidney impairment compared to healthy volunteers. A total of 16 adults received a single dose, and researchers measured drug levels and safety markers like heart activity and blood pressure. T…